SCHEMBL29630424

SCHEMBL29630424

NCCCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CO)C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ GSR P00390 1/20 0.50
▸ NMT1 P30419 5/20 0.49
▸ NMT2 O60551 4/20 0.49
▸ FOLH1 Q04609 1/20 0.47
▸ DPP8 Q6V1X1 1/20 0.45
▸ DPP9 Q86TI2 1/20 0.45
▸ DPP7 Q9UHL4 1/20 0.45
▸ TLR2 O60603 1/20 0.44
▸ MMP2 P08253 1/20 0.42
▸ GNAI3 P08754 1/20 0.41
▸ GNAO1 P09471 1/20 0.41
▸ GNAI1 P63096 1/20 0.41
▸ CPB2 Q96IY4 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29592035 1.00 GSR (0.50) GSRNMT1NMT2FOLH1DPP8
SCHEMBL29943324 1.00 GSR (0.50) GSRNMT1NMT2FOLH1DPP8
SCHEMBL30581338 1.00 GSR (0.50) GSRNMT1NMT2FOLH1DPP8
SCHEMBL30039547 0.98 GSR (0.51) GSRNMT1NMT2FOLH1DPP8
SCHEMBL30277638 0.98 GSR (0.51) GSRNMT1NMT2FOLH1DPP8
SCHEMBL30881170 0.97 GSR (0.50) GSRNMT1NMT2FOLH1DPP8
SCHEMBL30881181 0.97 GSR (0.50) GSRNMT1NMT2FOLH1DPP8
SCHEMBL24141455 0.97 GSR (0.53) GSRNMT1NMT2FOLH1DPP8
SCHEMBL30943792 0.97 GSR (0.53) GSRNMT1NMT2FOLH1DPP8
SCHEMBL29465874 0.97 GSR (0.53) GSRNMT1NMT2FOLH1DPP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250188139-A1 VEGF-C MUTEINS FOR SELECTIVE LYMPHATIC STIMULATION YALE UNIVERSITY (US) 2025-06-12 — — US disclosed
CN-119522235-A VEGF-C muteins for selective lymphatic stimulation 耶鲁大学 2025-02-25 — — CN disclosed
US-11807899-B2 Biochemical reaction methods and reagents comprising intrinsically disordered regions Biocrucible Limited 2023-11-07 — — US disclosed
US-20220145378-A1 BIOCHEMICAL REACTION METHODS AND REAGENTS COMPRISING INTRINSICALLY DISORDERED REGIONS Biocrucible Limited (GB) 2022-05-12 — — US disclosed
Send feedback